Personal information

No personal information available

Activities

Collapse all

Employment (1)

Technische Universität München: Freising, Bayern, DE

2021-04 to present | Ph.D. Candidate (Chair of Proteomics and Bioanalytics)
Employment
Source: Self-asserted source
Julian Müller

Education and qualifications (3)

Technische Universität München: Freising, Bayern, DE

2021-04 to present | Ph.D. (Chair of Proteomics and Bioanalytics)
Education
Source: Self-asserted source
Julian Müller

Eberhard Karls Universität Tübingen: Tubingen, Baden-Württemberg, DE

2018 to 2020 | Bioinformatics MSc (Computer Science)
Education
Source: Self-asserted source
Julian Müller

Eberhard Karls Universität Tübingen: Tubingen, Baden-Württemberg, DE

2014 to 2018 | Bioinformatics BSc (Computer Science)
Education
Source: Self-asserted source
Julian Müller

Works (8)

Decrypting the molecular basis of cellular drug phenotypes by dose-resolved expression proteomics

Nature Biotechnology
2025-03 | Journal article
DOI: 10.1038/s41587-024-02218-y
Contributors: Stephan Eckert; Nicola Berner; Karl Kramer; Annika Schneider; Julian Müller; Severin Lechner; Sarah Brajkovic; Amirhossein Sakhteman; Christian Graetz; Jonas Fackler et al.
Source: check_circle
Crossref

PTMNavigator: interactive visualization of differentially regulated post-translational modifications in cellular signaling pathways

Nature Communications
2025-01-08 | Journal article
DOI: 10.1038/s41467-024-55533-y
Contributors: Julian Müller; Florian P. Bayer; Mathias Wilhelm; Maximilian G. Schuh; Bernhard Kuster; Matthew The
Source: check_circle
Crossref

Oktoberfest: Open‐source spectral library generation and rescoring pipeline based on Prosit

PROTEOMICS
2024-04 | Journal article
DOI: 10.1002/pmic.202300112
Contributors: Mario Picciani; Wassim Gabriel; Victor‐George Giurcoiu; Omar Shouman; Firas Hamood; Ludwig Lautenbacher; Cecilia Bang Jensen; Julian Müller; Mostafa Kalhor; Armin Soleymaniniya et al.
Source: check_circle
Crossref

Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage response

2024-03-25 | Preprint
DOI: 10.1101/2024.03.22.586243
Contributors: Stefanie Höfer; Larissa Frasch; Kerstin Putzker; Joe Lewis; Amirhossein Sakhteman; Matthew The; Florian P. Bayer; Julian Müller; Firas Hamood; Bernhard Kuster
Source: check_circle
Crossref

Illuminating phenotypic drug responses of sarcoma cells to kinase inhibitors by phosphoproteomics

Molecular Systems Biology
2023-12-18 | Journal article
DOI: 10.1038/s44320-023-00004-7
Contributors: Chien-Yun Lee; Matthew The; Chen Meng; Florian P Bayer; Kerstin Putzker; Julian Müller; Johanna Streubel; Julia Woortman; Amirhossein Sakhteman; Moritz Resch et al.
Source: check_circle
Crossref

PTMNavigator: Interactive Visualization of Differentially Regulated Post-Translational Modifications in Cellular Signaling Pathways

2023-09-02 | Preprint
DOI: 10.1101/2023.08.31.555601
Contributors: Julian Müller; Florian P. Bayer; Mathias Wilhelm; Maximilian G. Schuh; Bernhard Kuster; Matthew The
Source: check_circle
Crossref

Decrypting drug actions and protein modifications by dose- and time-resolved proteomics

Science
2023-04-07 | Journal article
DOI: 10.1126/science.ade3925
Contributors: Jana Zecha; Florian P. Bayer; Svenja Wiechmann; Julia Woortman; Nicola Berner; Julian Müller; Annika Schneider; Karl Kramer; Mar Abril-Gil; Thomas Hopf et al.
Source: check_circle
Crossref

ProteomicsDB: toward a FAIR open-source resource for life-science research

Nucleic Acids Research
2022-01-07 | Journal article
DOI: 10.1093/nar/gkab1026
Part of ISSN: 0305-1048
Part of ISSN: 1362-4962
Source: Self-asserted source
Julian Müller
How many people are using ORCID?